COVID-19 Research at Georgia State: Researchers Find Rheumatoid Arthritis Drug Is Effective at Inhibiting Novel Coronavirus
COVID-19 Research at Georgia State: Researchers Find Rheumatoid Arthritis Drug Is Effective at Inhibiting Novel Coronavirus
Auranofin, a drug approved by the U.S. Food & Drug Administration (FDA) to treat rheumatoid arthritis, is effective at inhibiting the novel coronavirus, known as SARS-CoV-2, Georgia State University researchers have found.
The researchers tested the drug as part of a project to screen FDA-approved medications for their potential use against SARS-CoV-2. They have made the paper publicly available for the global research and healthcare community on the preprint website bioRxiv.
“Drug repurposing is the fastest way to get a treatment for SARS-CoV-2 because it’s already been established that these medicines are safe to use in humans,” said Mukesh Kumar, lead author of the study and assistant professor of biology.
